Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Eliza Kramer to Transforming Growth Factor beta

This is a "connection" page, showing publications Eliza Kramer has written about Transforming Growth Factor beta.

 
Connection Strength
 
 
 
1.966
 
  1. Scharf G, Davidson CR, Ustiyan V, Falkenberg LG, Adavalli A, Meeker JD, Morgan H, Ostmann AJ, Hudock KM, Brewington JJ, Clancy JP, Kramer EL. TGF-ß induces excessive pulmonary IL-6 secretion in cystic fibrosis via PI3K. Am J Physiol Lung Cell Mol Physiol. 2025 10 01; 329(4):L470-L479.
    View in: PubMed
    Score: 0.745
  2. Kramer EL, Madala SK, Hudock KM, Davidson C, Clancy JP. Subacute TGFß Exposure Drives Airway Hyperresponsiveness in Cystic Fibrosis Mice through the PI3K Pathway. Am J Respir Cell Mol Biol. 2020 05; 62(5):657-667.
    View in: PubMed
    Score: 0.514
  3. Kramer EL, Clancy JP. TGFß as a therapeutic target in cystic fibrosis. Expert Opin Ther Targets. 2018 02; 22(2):177-189.
    View in: PubMed
    Score: 0.436
  4. Kramer EL, Hudock KM, Davidson CR, Clancy JP. CFTR dysfunction in smooth muscle drives TGFß dependent airway hyperreactivity. Respir Res. 2023 Aug 11; 24(1):198.
    View in: PubMed
    Score: 0.161
  5. Kramer EL, Clancy JP. MicroRNA-145, Cystic Fibrosis Transmembrane Conductance Regulator, and Transforming Growth Factor-ß. An (Un)tangled Regulatory Web. Am J Respir Crit Care Med. 2018 03 01; 197(5):551-552.
    View in: PubMed
    Score: 0.111
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)